Liminatus Pharma
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell LIMN and other ETFs, options, and stocks.About LIMN
Liminatus Pharma, Inc. is a pre-clinical stage biopharmaceutical company, which engages in developing novel, immune-modulating cancer therapies. The company was founded on November 1, 2020 and is headquartered in Cerritos, CA.
LIMN Key Statistics
Stock Snapshot
Liminatus Pharma(LIMN) stock is priced at $3.41, giving the company a market capitalization of 4.99M. It carries a P/E multiple of -0.16.
During the trading session on 2026-10-13, Liminatus Pharma(LIMN) shares reached a daily high of $3.63 and a low of $3.41. At a current price of $3.41, the stock is 0.0% higher than the low and still -5.9% under the high.
Trading volume for Liminatus Pharma(LIMN) stock has reached 13.55K, versus its average volume of 21.35K.
The stock's 52-week range extends from a low of $3.29 to a high of $141.50.
The stock's 52-week range extends from a low of $3.29 to a high of $141.50.
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.